drugset / Trial / NCT01244178

Hyperinsulinemic Therapy in Sepsis

NCT01244178

Unknown 15 enrolled peter metrakos
RandomizedFactorialOpen-labelTreatment

Summary

Insulin regulates blood sugar and acts to suppress inflammation. Hyperinsulinemic Therapy is a protocol for Insulin administration that involves the administration of a calculated higher dose of insulin into the blood stream. This therapy is called dextrose/insulin clamp. It has been shown to be safe and successful in maintaining normal glucose levels. The objective of the study is to assess if the clamp can achieve a steady and normal blood glucose level in patients admitted to the intensive care unit with sepsis. Furthermore, if the higher insulin dose would lead to a drop in the inflammatory response seen in septic patients.

Timeline

Start
2010-11
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Intravenous